TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ADAG

Adagene Inc

Healthcare · Biotechnology

3.20$ +9.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ADAG
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – –
– -10.2% +5.1% +31.1% +28.8% -16.6% -23.4% -36.3%
– +383.4% +1,555.9% +84.4% -43.7% -30.9% -32.5% -23.8%
– – – +79.1% – – – –
– -473.4% – +318.2% +134.7% -175.4% – –
– -70.5% +516.0% +168.4% -72.5% -87.7% -60.5% -49.2%
– – -71.5% -135.5% -72.7% -88.7% – -57.0%
– – – – -93.0% – – –
– – – – +68.4% -100.0% – –
– -77.8% +2,039.1% -114.0% – -125.0% -36.3% +257.5%
– +36.5% -93.6% +3,174.3% -87.7% -130.1% – +17.9%
– +944.4% -122.7% – -130.9% – – –
– – – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?